[1] |
JIANG Wenshuo, YANG Li.
Adverse drug reaction among 694 patients in an epilepsy physician-pharmacist joint clinic
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 102-106.
|
[2] |
FAN Xiucong, DONG Xiaohui, CHEN Danxia, BAO Siwei, MA Yabin.
Pharmaceutical care of a patient with Clostridium difficile infection and urinary tract infection during pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 579-582.
|
[3] |
LI Meng, LI Rongrong, LIU Chenghai.
Clinic diagnosis and treatment of herb-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 127-131.
|
[4] |
YUAN Xiaolong, WAN Qihua, TAO Donghong, QI Hao, WANG Aixia.
Pharmaceutical care of a severely poisoned patient with methotrexate tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 924-928.
|
[5] |
ZHU Jinying, ZHOU Sufeng, WANG Lu, XU Mingzhe, SHAO Feng.
Advances in pediatric drug for central sedation based on pharmacokinetic/pharmacodynamic modeling and simulation
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 721-727.
|
[6] |
WEI Xianni, XU Huiyi, HUANG Yuhong, XIE Genying.
Influencing factors and treatment of drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 665-669.
|
[7] |
SU Xinxin, LI Lixun, WANG Zhifei, XIE Yanming, WANG Qi.
Real-world study on Xiyanping injection combined in the treatment of childhood pneumonia
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 47-51.
|
[8] |
MA Yini, ZHANG Lixiang, ZHANG Zhetao, WANG Xiaoyu, SHI Tianlu.
Adverse Drug Reactions of Anti-thyroid Drugs and Effects of 131I Replacement Therapy in Patients with Hyperthyroidism
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 469-472.
|
[9] |
FAN Yan, WANG Dan, WANG Chunting.
The Mechanism of Toxicity Reaction Induced by Protamine Sulfate Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1159-1161.
|
[10] |
ZHANG Xiaowen, HOU Wenbin, YANG Ming, LIU Jianping.
Opportunities and Challenges of Pharmacovigilance in Cancer Treatment
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1034-1038.
|
[11] |
ZHENG Xue, SI Jigang.
Research Progress of Weight Gain Induced by Antidepressants
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 444-447.
|
[12] |
TIAN Di, WANG Lin, GE Ziruo, CUI Shuping, CHEN Zhihai.
Present Situation and Prospect of Antiviral Treatments for COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(3): 129-135.
|
[13] |
CHEN Chong, GE Ziruo, WANG Lin, CHEN Zhihai.
Analysis and Prospect of Domestic and Foreign Plague Antibacterial Treatment Plan
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(1): 1-5.
|
[14] |
WANG Ying, YIN Peng, GUAN Liying, ZHU Kun.
Pharmaceutical Care for an Acute Myeloid Leukemia Patient with Agranulocytosis with Fever
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 561-565.
|
[15] |
ZHAN Hai-yan, YANG Jian.
Analysis on 382 Cases of Medication and Drug Adverse Reactions of Protamine Sulfate Injection in a Hospital from 2015 to 2017
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(1): 41-44.
|